INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 31 filers reported holding INTEC PHARMA LTD JERUSALEM in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $48,000 | -66.2% | 65,649 | +101.3% | 0.00% | -69.2% |
| Q2 2019 | $142,000 | -69.6% | 32,609 | -48.8% | 0.01% | -71.1% |
| Q1 2019 | $467,000 | -15.9% | 63,692 | -13.5% | 0.04% | -44.4% |
| Q4 2018 | $555,000 | +228.4% | 73,669 | +146.3% | 0.08% | +376.5% |
| Q3 2018 | $169,000 | +53.6% | 29,905 | +19.7% | 0.02% | +70.0% |
| Q2 2018 | $110,000 | – | 24,982 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 809,804 | $4,140,000 | 0.60% |
| SABBY MANAGEMENT, LLC | 514,878 | $2,652,000 | 0.14% |
| Migdal Insurance & Financial Holdings Ltd. | 497,200 | $2,542,000 | 0.06% |
| Renaissance Technologies | 12,944 | $66,000 | 0.00% |
| DEUTSCHE BANK AG\ | 12,724 | $65,000 | 0.00% |